{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T07:08:15Z","timestamp":1779433695151,"version":"3.53.1"},"reference-count":37,"publisher":"Centre for Evaluation in Education and Science (CEON\/CEES)","issue":"5","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/BY\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Med Biochemistry"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:p>Background: To investigate the expression of coagulation markers and their correlations with immunological function and inflammation in patients with autoimmune diseases (Sjogren's syndrome and rheumatoid arthritis). Methods: A total of 183 patients were selected for the study: 61 RA patients who made up the RA group were admitted to our hospital between December 2023 and December 2024, 61 pSS patients composed the pSS group, and 61 normal physical examinees who were in the physical examination centre of our hospital during the same period composed the control group. Baseline clinical indicators of patients in each group before treatment were collected, including the plasma prothrombin time (PT), international normalised ratio (INR), thrombin time (TT), plasma fibrinogen (FBG), partial thromboplastin time (APTT), fibrinogen degradation products (FDP), and plasma D-dimer (D-D). Results: The expression levels of Pt FBG, T T FDP and DD in the RA group, the pSS group and the normal group were significantly different. The expression levels of PT, FBG, FDP and D-D in the RA group were all greater than those in the pSS group and the control group. The expression level of PT in the pSS group was greater than that in the control group. Analysis of the receiver operating characteristic (ROC) curve showed that, in contrast to those in the normal group, the area under the curve (AUC) of PT in the RA group was 0.638, the AUC of FBG was 0.899, the AUC of FDP was 0.866, and the AUC of D-D was 0.919. The AUC of the combined diagnosis of RA by coagulation indicators was greater than that of the individual detection of each indicator. Compared with that in the normal group, the AUC of PT in the pSS group was 0.618 (P = 0.025), and the AUC of T T was 0.645 (P=0.006). The AUC of the combined diagnosis of coagulation indicators for pSS was greater than that of the individual detection of each indicator. Higher D-D in RA patients was significantly associated with higher levels of hs-CRP CCP and RF, while higher FBG was significantly associated with higher levels of hs-CRP ESR, RF and CCP Correlation analysis revealed that in the RA group, PT, INR, FBG, FDP and D-D were positively correlated with CRP and ESR. On the other hand, T T was negatively correlated with CRP and ESR. FBG, FDP and D-D in the pSS group were positively correlated with CRP and ESR. In addition, the coagulation indicators in the RA group were positively correlated with the immune indicators, whereas in the pSS group, they were partially negatively correlated, both of which were significant. In addition, the coagulation indicators in the RA group were positively correlated with the immune indicators, whereas in the pSS group, they were partially negatively correlated, both of which were significant. In patients with pSS, FBG and FDP are positively correlated with hs-CRP and A PTT and ESR are positively correlated with FBG. Conclusions: Compared with those of pSS, PT, FBG, FDP, and D-D, these markers have a greater diagnostic value for the early detection of RA and the assessment of disease severity, and can be used as critical predictive indicators for the confirmed diagnosis of RA.<\/jats:p>","DOI":"10.5937\/jomb0-60937","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T09:52:58Z","timestamp":1762336378000},"page":"1023-1034","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of inflammatory immune correlation of the coagulation spectrum, PT, FBG, FDP, D-D in autoimmune diseases"],"prefix":"10.5937","volume":"45","author":[{"given":"Yinghong","family":"Zhong","sequence":"first","affiliation":[{"name":"Meizhou People's Hospital, Department of Haematology, Meizhou City, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"He","sequence":"additional","affiliation":[{"name":"Women and Children's Hospital Affiliated to Xiamen University Xiamen Maternal and Child Health Hospital, Department of Emergency, Xiamen City, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Geng","sequence":"additional","affiliation":[{"name":"Jinan Blood Centre, Department of Haematology, Jinan City, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Huang","sequence":"additional","affiliation":[{"name":"Western Theatre Command Air Force Hospital, Department of Laboratory Medicine, Chengdu City, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Zhang","sequence":"additional","affiliation":[{"name":"West China Hospital of Sichuan University, Department of Cardiology, Chengdu City, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuezhong","family":"Ren","sequence":"additional","affiliation":[{"name":"West China Hospital of Sichuan University, Department of Cardiology, Chengdu City, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[{"name":"Xinchang County People's Hospital, Department of Haematology, Shaoxing City, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3964","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Huang YJ, Han L, Li J, Chen C. Acquired coagulation dysfunction resulting from vitamin K-dependent coagulation factor deficiency associated with rheumatoid arthritis: A case report. World J Clin Cases 2022 Jan 7; 10(1): 236-41. doi: 10.12998\/wjcc.v10.i1.236. PMID: 35071522; PMCID: PMC8727243;","DOI":"10.12998\/wjcc.v10.i1.236"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Wang F, Liu J, Wang Y, Sun Y, Wen J, He M. Correlation Analysis of Coagulation and Platelet Parameters with Clinical Outcomes in Rheumatoid Arthritis Patients and the Interventional Effect of Jianpi Huashi Tongluo Formula - Xinfeng Capsule: A Post Hoc Analysis Based on a Randomized Controlled Trial. Drug Des Devel Ther 2025 Apr 29; 19: 3477-95. doi: 10.2147\/DDDT.S512338. PMID: 40322027; PMCID: PMC12049676;","DOI":"10.2147\/DDDT.S512338"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Delcheva G, Stefanova K, Stankova T, Maneva A. Serum thioredoxin and lactoferrin in rheumatoid arthritis and their association with rheumatoid factor. J Med Biochem 2025; 44(2): 312-8. doi: 10.5937\/jomb0-44758;","DOI":"10.5937\/jomb0-44758"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Hassan FA, Elkassas NEM, El-Bltagy EA, Mohamed MS, Mobarez S, Salim IH, Abdel-Aal MM. Dietary zinc-chitosan nanoparticles addition influences on growth performance, apparent total tract digestibility, carcass indices, and immune function in weaned rabbits. Anim Biotechnol 2023 Dec; 34(9): 4819-27. doi: 10.1080\/10495398.2023.2197467. Epub 2023 Apr 13. PMID: 37051844;","DOI":"10.1080\/10495398.2023.2197467"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Zhang J, Chen J, Yang X, Han J, Chen X, Fan Y, Zheng H. Novel risk prediction models, involving coagulation, thromboelastography, stress response, and immune function indicators, for deep vein thrombosis after radical resection of cervical cancer and ovarian cancer. J Obstet Gynecol 2023 Dec; 43(1): 2204162. doi: 10.1080\/01443615.2023.2204162. PMID: 37089113;","DOI":"10.1080\/01443615.2023.2204162"},{"key":"#cr-split#-ref6.1","doi-asserted-by":"crossref","unstructured":"Liu Y, Zhang A, Guo N, Hao Q, Li F. A pattern recognition receptor ficolin from Portunus trituberculatus (Ptficolin) regulating immune defense and hemolymph coagulation. Int J Biol Macromol 2022 Nov 30","DOI":"10.1016\/j.ijbiomac.2022.09.041"},{"key":"#cr-split#-ref6.2","doi-asserted-by":"crossref","unstructured":"221: 558-72. doi: 10.1016\/j.ijbiomac.2022.09.041. Epub 2022 Sep 9. PMID: 36089094;","DOI":"10.1016\/j.ijbiomac.2022.09.041"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Chen W, Zhao X, Lu Y, Wang H, Wang X, Wang Y, Liang C, Jia Z, Ma W. Clinical significance, molecular characterisation, and immune microenvironment analysis of coagulation-related genes in clear cell renal cell carcinoma. Cancer Innov 2024 Jan 7; 3(1): e105. doi: 10.1002\/cai2.105. PMID: 38948537; PMCID: PMC11212306;","DOI":"10.1002\/cai2.105"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Wu L, Li H, Liu Y, Fan Z, Xu J, Li N, Qian X, Lin Z, Li X, Yan J. Research progress of 3D-bioprinted functional pancreas and in vitro tumor models. International Journal of Bioprinting 2024; 10(1): 1256. doi: 10.36922\/ijb.1256;","DOI":"10.36922\/ijb.1256"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Zhang X, Huang H. Comparison of the efficacy and impact on coagulation function of different rituximab dosage regimens in the treatment of membranous nephropathy. Am J Transl Res 2025 Mar 15; 17(3): 1974-84. doi: 10.62347\/WQAB1378. PMID: 40226032; PMCID: PMC11982884;","DOI":"10.62347\/WQAB1378"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Tao J, Wang L, Gu Z, Zhang L. Effect of Bortezomib Treatment in Multiple Myeloma on Blood Coagulation Function, Renal Function, Immune Function, and the NF-kB Pathway-Associated Indicators. Br J Hosp Med (Lond) 2025 Mar 26; 86(3): 1-15. doi: 10.12968\/hmed.2024.0701. PMID: 40135312;","DOI":"10.12968\/hmed.2024.0701"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Wu L, Zheng Y, Liu J, Luo R, Wu D, Xu P, Wu D, Li X. Comprehensive evaluation of the efficacy and safety of LPV\/r drugs in the treatment of SARS and MERS to provide potential treatment options for COVID-19. Aging (Albany NY) 2021 Apr 20; 13(8): 10833-52. doi: 10.18632\/aging.202860. Epub 2021 Apr 20. PMID: 33879634; PMCID: PMC8109137;","DOI":"10.18632\/aging.202860"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Wu T, Wu S, Li M, Zhang J. Comparison of the Correlation Between Coagulation Indices and Rivaroxaban Concentrations. Ann Pharmacother 2024 Jan; 58(1): 28-36. doi: 10.1177\/10600280231158929. Epub 2023 Apr 26. PMID: 37125735;","DOI":"10.1177\/10600280231158929"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Fang X, Fu W, Xu L, Qiu Y. Analysis of the diagnostic value of coagulation markers and coagulation function indices on the occurrence of DIC in sepsis and its prognosis. Allergol Immunopathol (Madr) 2024 Sep 1; 52(5): 65-72. doi: 10.15586\/aei.v52i5.1119. PMID: 39278853;","DOI":"10.15586\/aei.v52i5.1119"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Wu L, Zhong Y, Wu D, Xu P, Ruan X, Yan J, Liu J, Li X. Immunomodulatory Factor TIM3 of Cytolytic Active Genes Affected the Survival and Prognosis of Lung Adenocarcinoma Patients by Multi-Omics Analysis. Biomedicines 2022 Sep 10; 10(9): 2248. doi: 10.3390\/biomedicines10092248. PMID: 36140350; PMCID: PMC9496572;","DOI":"10.3390\/biomedicines10092248"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Yang H, Yuan Y, Shi L, Yang Y, Zhu Y, Chen Y. Enhanced diagnostic capabilities of thromboelastography coupled with standard coagulation indices for predicting perioperative thrombosis in older individuals with hip fractures: TEG coupled with standard coagulation indices for predicting thrombosis in hip fractures. J Orthop Surg Res 2024 Dec 24; 19(1): 870. doi: 10.1186\/s13018-024-05386-4. PMID: 39719587; PMCID: PMC11667881;","DOI":"10.1186\/s13018-024-05386-4"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Radenkovic S, Bleukx S, Engelhardt N, Eklund E, Mercimek-Andrews S, Edmondson AC, Morava E. Coagulation abnormalities and vascular complications are common in PGM1-CDG. Mol Genet Metab 2024 Aug; 142(4): 108530. doi: 10.1016\/j.ymgme.2024.108530. Epub 2024 Jul 2. PMID: 38968673;","DOI":"10.1016\/j.ymgme.2024.108530"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Wang Y, Li Y, Zhou Y, Gao Y, Zhao L. Guanxinning Tablet Alleviates Post-Ischemic Stroke Injury Via Regulating Complement and Coagulation Cascades Pathway and Inflammatory Network Mobilization. Drug Des Devel Ther 2024 Sep 18; 18: 4183-202. doi: 10.2147\/DDDT.S479881. PMID: 39308695; PMCID: PMC11416781;","DOI":"10.2147\/DDDT.S479881"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Wu L, Liu Q, Ruan X, Luan X, Zhong Y, Liu J, Yan J, Li X. Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD). Biomedicines 2023 Jun 29; 11(7): 1861. doi: 10.3390\/biomedicines11071861. PMID: 37509501; PMCID: PMC10377220;","DOI":"10.3390\/biomedicines11071861"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Wu L, Li X, Qian X, Wang S, Liu J, Yan J. Lipid Nanoparticle (LNP) Delivery Carrier-Assisted Targeted Controlled Release mRNA Vaccines in Tumor Immunity. Vaccines (Basel) 2024 Feb 12; 12(2): 186. doi: 10.3390\/vaccines12020186. PMID: 38400169; PMCID: PMC10891594;","DOI":"10.3390\/vaccines12020186"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Wu L, Zheng Y, Ruan X, Wu D, Xu P, Liu J, Wu D, Li X. Long-chain noncoding ribonucleic acids affect the survival and prognosis of patients with esophageal adenocarcinoma through the autophagy pathway: construction of a prognostic model. Anticancer Drugs 2022 Jan 1; 33(1): e590-e603. doi: 10.1097\/CAD.0000000000001189. PMID: 34338240; PMCID: PMC8670349;","DOI":"10.1097\/CAD.0000000000001189"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Cao G, Zhang S, Wang Y, Xu H, Quan S, Cai L, Feng W, Yao J, Tan H, Pei F. The efficacy and safety of tranexamic acid in rheumatoid arthritis patients undergoing simultaneous bilateral total knee arthroplasty: a multicenter retrospective study. BMC Musculoskelet Disord 2023 May 15; 24(1): 379. doi: 10.1186\/s12891-023-06485-9. PMID: 37189066; PMCID: PMC10184364;","DOI":"10.1186\/s12891-023-06485-9"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Yang Y, Zhang L, Zhao X, Li J, Chen Q, Gao Y, Yan J. Evaluation of the prognostic value of coagulation function and cerebral hemodynamic changes in acute ischemic stroke patients with rheumatoid arthritis. Ann Biol Clin (Paris) 2025 May 22; 83(2): 185-94. doi: 10.1684\/abc.2025.1965. PMID: 40341111;","DOI":"10.1684\/abc.2025.1965"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Wu L, Chen X, Zeng Q, Lai Z, Fan Z, Ruan X, Li X, Yan J. NR5A2 gene affects the overall survival of LUAD patients by regulating the activity of CSCs through SNP pathway by OCLR algorithm and immune score. Heliyon 2024 Mar 28; 10(7): e28282. doi: 10.1016\/j.heliyon.2024.e28282. PMID: 38601554; PMCID: PMC11004709;","DOI":"10.1016\/j.heliyon.2024.e28282"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Fukami Y, Koike H, Iijima M, Mouri N, Nishi R, Katsuno M. Role of complement components in vasculitic neuropathy associated with systemic lupus erythematosus and rheumatoid arthritis. Muscle Nerve 2022 Aug; 66(2): 175-82. doi: 10.1002\/mus.27636. Epub 2022 Jun 1. PMID: 35581952;","DOI":"10.1002\/mus.27636"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Mariette X, Borchmann S, Aspeslagh S, Szekanecz Z, Charles-Schoeman C, Schreiber S, Choy EH, Peyrin-Biroulet L, Schmalzing M, Tanaka Y, Ten Cate H, Westhovens R, van der Woude CJ, Ekoka Omoruyi EV, Faes M, Masior T, Van Hoek P, Watson C, Rudolph C, Stallmach A. Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmes. RMD Open 2025 Mar 4; 11(1): e005033. doi: 10.1136\/rmdopen-2024-005033. PMID: 40037922; PMCID: PMC11881192;","DOI":"10.1136\/rmdopen-2024-005033"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Tsai YC, Chang HC, Chiou MJ, Luo SF, Kuo CF. Fetal-neonatal and maternal pregnancy outcomes in women with rheumatoid arthritis: a population-based cohort study. BMJ Open 2022 Oct 26; 12(10): e059203. doi: 10.1136\/bmjopen-2021-059203. PMID: 36288841; PMCID: PMC9615975;","DOI":"10.1136\/bmjopen-2021-059203"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Yu J, Hu C, Dai Z, Xu J, Zhang L, Deng H, Xu Y, Zhao L, Li M, Liu L, Zhang M, Huang J, Wu L, Chen G. Dipeptidyl peptidase 4 as a potential serum biomarker for disease activity and treatment response in rheumatoid arthritis. Int Immunopharmacol 2023 Jun; 119: 110203. doi: 10.1016\/j.intimp.2023.110203. Epub 2023 Apr 24. PMID: 37094543;","DOI":"10.1016\/j.intimp.2023.110203"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Wu L, Zhong Y, Yu X, Wu D, Xu P, Lv L, Ruan X, Liu Q, Feng Y, Liu J, Li X. Selective polyadenylation predicts the efficacy of immunotherapy in patients with lung adenocarcinoma by multiple omics research. Anticancer Drugs 2022 Oct 1; 33(9): 943-59. doi: 10.1097\/CAD.0000000000001319. Epub 2022 Aug 9. PMID: 35946526; PMCID: PMC9481295;","DOI":"10.1097\/CAD.0000000000001319"},{"key":"#cr-split#-ref29.1","doi-asserted-by":"crossref","unstructured":"Lin YY, Huang CC, Ko CY, Tsai CH, Chang JW, Achudhan D, Tang CH. Omentin-1 modulates interleukin expression and macrophage polarisation: Implications for rheumatoid arthritis therapy. Int Immunopharmacol 2025 Mar 6","DOI":"10.1016\/j.intimp.2025.114205"},{"key":"#cr-split#-ref29.2","doi-asserted-by":"crossref","unstructured":"149: 114205. doi: 10.1016\/j.intimp.2025.114205. Epub 2025 Feb 4. PMID: 39908806;","DOI":"10.1016\/j.intimp.2025.114205"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Aripova N, Duryee MJ, England BR, Hunter CD, Mordeson JE, Ryan EM, Daubach EC, Romberger DJ, Thiele GM, Mikuls TR. Citrullinated and malondialdehyde-acetaldehyde modified fibrinogen activates macrophages and promotes an aggressive synovial fibroblast phenotype in patients with rheumatoid arthritis. Front Immunol 2023 Aug 16; 14: 1203548. doi: 10.3389\/fimmu.2023.1203548. PMID: 37654483; PMCID: PMC10467288;","DOI":"10.3389\/fimmu.2023.1203548"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Yao M, Huang X, Guo Y, Zhao JV, Liu Z. Disentangling the common genetic architecture and causality of rheumatoid arthritis and systemic lupus erythematosus with COVID-19 outcomes: Genome-wide cross trait analysis and bidirectional Mendelian randomisation study. J Med Virol 2023 Feb; 95(2): e28570. doi: 10.1002\/jmv.28570. PMID: 36762574;","DOI":"10.1002\/jmv.28570"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"Wu L, Yang L, Qian X, Hu W, Wang S, Yan J. Mannan-Decorated Lipid Calcium Phosphate Nanoparticle Vaccine Increased the Antitumor Immune Response by Modulating the Tumor Microenvironment. J Funct Biomater 2024 Aug 16; 15(8): 229. doi: 10.3390\/jfb15080229. PMID: 39194667; PMCID: PMC11355305;","DOI":"10.3390\/jfb15080229"},{"key":"#cr-split#-ref33.1","doi-asserted-by":"crossref","unstructured":"Hansildaar R, Raadsen R, Gerritsen M, Nagy M, Dijkshoorn B, Spronk HMH, Ten Cate H, Nurmohamed MT. Comparative Analysis of Coagulation Activation in Rheumatoid Arthritis Patients Treated With TNF Inhibitors Versus JAK Inhibitors: A Longitudinal Study. J Clin Rheumatol 2024 Dec 1","DOI":"10.1097\/RHU.0000000000002136"},{"key":"#cr-split#-ref33.2","doi-asserted-by":"crossref","unstructured":"30(8): e166-e171. doi: 10.1097\/RHU.0000000000002136. Epub 2024 Sep 30. PMID: 39342416;","DOI":"10.1097\/RHU.0000000000002136"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"Kratz EM, Kacperczyk M, Kokot I, Piwowar A, Konopska B, Sokolik R, Korman L. Glycosylation Pattern of Serum Clusterin in Psoriatic Arthritis and Rheumatoid Arthritis-The Search for New Diagnostic Glycomarkers. Int J Mol Sci 2024 Dec 5; 25(23): 13060. doi: 10.3390\/ijms252313060. PMID: 39684771; PMCID: PMC11642323;","DOI":"10.3390\/ijms252313060"}],"container-title":["Journal of Medical Biochemistry"],"original-title":["Analiza veze izme\u0111u inflamatorno-imunih faktora i koagulacionog spektra (PT, FBG, FDP, D-DIMER) kod autoimunih bolesti"],"language":"en","link":[{"URL":"https:\/\/aseestant.ceon.rs\/index.php\/jomb\/article\/download\/60937\/29278","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/scindeks-clanci.ceon.rs\/data\/pdf\/1452-8258\/2026\/1452-82582605023Z.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T06:42:47Z","timestamp":1779432167000},"score":1,"resource":{"primary":{"URL":"https:\/\/scindeks.ceon.rs\/Article.aspx?artid=1452-82582605023Z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.5937\/jomb0-60937","relation":{},"ISSN":["1452-8258","1452-8266"],"issn-type":[{"value":"1452-8258","type":"print"},{"value":"1452-8266","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]}}}